Systemic Inflammatory Response Syndrome Treatment Market Size & Share, by Indication Type (Meningitis, Urinary Tract Infection (UTI), Pneumonia, Hemorrhage, Autoimmune Diseases), by End User (Hospital & Ambulatory Surgical Centers, Specialty Clinics) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 3013
  • Published Date: Sep 23, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Systemic Inflammatory Response Syndrome Treatment Market size was valued at USD 12.85 billion in 2023 and is projected to exceed USD 27.75 billion by the end of 2036, registering over 6.1% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of systemic inflammatory response syndrome treatment is evaluated at USD 13.48 billion.

Increasing incidences of systemic inflammatory response syndrome disease due to lifestyle changes, raising awareness about the disease, and the availability of treatments is expected to fuel this market's progress. The growth of the market can also be attributed to the rising prevalence of SIRS disease amongst individuals on a global level. 


Systemic-Inflammatory-Response-Syndrome-Treatment-Market-Size
Get more information on this report: Request Free Sample PDF

Systemic Inflammatory Response Syndrome Treatment Sector: Growth Drivers and Challenges

Growth Drivers

  • Increasing incidence of systemic inflammatory response syndrome due to lifestyle changes
  • Increasing awareness about the disease, and the availability of treatments

Challenges

  • High cost of treatment
  • Delay in diagnosis and lack of awareness

Systemic Inflammatory Response Syndrome Treatment Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

6.1%

Base Year Market Size (2023)

USD 12.85 billion

Forecast Year Market Size (2036)

USD 27.75 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
 
Get more information on this report: Request Free Sample PDF

Systemic Inflammatory Response Syndrome Treatment Segmentation

On the basis of indication type, the systemic inflammatory response syndrome treatment market is segmented into meningitis, urinary tract infection (UTI), pneumonia, hemorrhage, autoimmune diseases, and others. Out of which, revenue from the treatment of urinary tract infection holds the highest share as dehydration, high consumption of birth control pills, menopause, and frequent involvement in sexual activities are leading causes of UTI. Females are more prone to UTI as they have a shorter urethra than males as a result, which shortens the distance for bacteria to reach the bladder.

On the basis of end-users, the market is segmented into hospital & ambulatory surgical centers, specialty clinics, and others. Specialty clinics segment hold the highest share of the systemic inflammatory response syndrome treatment market as a considerable portion of the population with disease on a global level tend to choose healthcare facilities specializing in specific treatment.

Our in-depth analysis of the global market includes the following segments:

           By Type

  • Meningitis
  • Urinary Tract Infection (UTI)
  • Pneumonia
  • Hemorrhage
  • Autoimmune Diseases
  • Others

             By End User

  • Hospitals & Ambulatory Surgical Centers
  • Specialty Clinics
  • Others
 

 

 


Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Systemic Inflammatory Response Syndrome Treatment Industry - Regional Synopsis

Geographically, the systemic inflammatory response syndrome treatment market is segmented into North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa region. The market in the Asia Pacific industry is anticipated to account for largest revenue share by 2036, owing to increasing awareness about the disease and the need to develop innovative inflammatory disease treatment solutions in the region.

In 2021, the market in North America is evaluated to occupy the largest share in terms of revenue followed by Europe.

 

Research Nester
Systemic-Inflammatory-Response-Syndrome-Treatment-Market-Share
Get more information on this report: Request Free Sample PDF

Companies Dominating the Systemic Inflammatory Response Syndrome Treatment Landscape

    • RegeneRx Biopharmaceuticals, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Endacea, Inc.
    • Adrenomed AG
    • GlaxoSmithKline plc
    • Asahi Kasei Corporation
    • Cardinal Health
    • Smith & Nephew plc
    • ConvaTec, Inc.
    • AstraZeneca
    • Orion Corporation
    • CHIESI Farmaceutici S.p.A.
    • Mylan N.V.

     


Author Credits:  Radhika Pawar


  • Report ID: 3013
  • Published Date: Sep 23, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing incidence of bowel disorders such as systemic inflammatory response syndrome due to lifestyle changes and increasing awareness about the disease are the key growth drivers.

The market is anticipated to attain a moderate CAGR over the forecast period, i.e., 2021-2029.

High cost of treatment and delay in diagnosis are estimated to hamper market growth.

The market in Asia Pacific region will provide ample growth opportunities owing to the increasing awareness about systemic inflammatory response syndrome.

The major players dominating the SIRS treatment market are Endacea, Inc., Adrenomed AG, GlaxoSmithKline plc, Asahi Kasei Corporation, Cardinal Health, among others.
Systemic Inflammatory Response Syndrome (SIRS) Treatment Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample